Co-occurring mutations in the POLE exonuclease and non-exonuclease domains define a unique subset of highly mutagenic tumors. https://www.biorxiv.org/content/10.1101/2022.12.15.520593v1?med=mas
Co-occurring mutations in the POLE exonuclease and non-exonuclease domains define a unique subset of highly mutagenic tumors. https://www.biorxiv.org/content/10.1101/2022.12.15.520593v1?med=mas